Sponsors

Mycoplasma pneumoniae monoclonal antibodies

Mycoplasma pneumoniae is a parasitic pathogen of the human respiratory tract. This bacterium lacks a cell wall and thus many antibiotics that inhibit cell wall synthesis are ineffective as treatment. M. pneumoniae causes atypical pneumonia and affects children and young adults most commonly. The organism adheres to respiratory epithelial cells via several adhesins. The P1 adhesin is a major virulence factor of this organism.

ViroStat has now released a new set of monoclonal antibodies to the P1 adhesin of M. pneumoniae. These new antibodies function well in immunofluorescence antibody (IFA) staining and as enzyme-linked immunosorbent assay (ELISA) pairs for the detection of the P1 antigen. These antibodies join the existing collection of ViroStat M. pneumoniae antibody reagents.
www.virostat-inc.com

Latest Issues

GenQA at ESCV 2025

Thessaloniki Concert Hall
17 September, 2025

IBMS Congress

The International Convention Centre (ICC), Birmingham
22-25 September, 2025

Diagnostics North East Conference 2025

The Catalyst, Newcastle
3 October

Delivering POCT: Diagnostics in the Community

Manchester Conference Centre
8 October